Clinical Trial Update: A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating bicalutamide with brain re-irradiation for recurrent high-grade glioma/glioblastoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• High-grade Glioma

Drugs mentioned

• bicalutamide (bicalutamide)

Snippet

Sponsor: University of Nebraska | Conditions: Recurrent Glioblastoma, Recurrent High-grade Glioma | Phase 1 | Status: WITHDRAWN